Avance Clinical News
-
Avance Clinical To Showcase Asia-Pacific Clinical Trial Expertise At BIO Korea 2025
4/15/2025
Avance Clinical, a leading full-service global Contract Research Organization (CRO) specializing in high-quality, agile clinical biotech research services, will attend BIO Korea 2025 to meet with biotechs and share clinical trial capabilities across the region including Australia, New Zealand, South Korea, Taiwan, North America and beyond.
-
Global Reach For Biotechs: Avance Clinical Secures MOUs With Four Premier Taiwanese Trial Sites
3/24/2025
Avance Clinical, a leading full-service global Contract Research Organization (CRO) specializing in high-quality, agile clinical biotech research services, is pleased to announce the signing of four Memorandums of Understanding (MOUs) with key clinical trial sites in Taiwan this week.
-
Avance Clinical Expands In Asia With Taipei Office To Accelerate Biotech Clinical Trials
3/24/2025
Avance Clinical, the award-winning, full-service Contract Research Organization (CRO) specializing in delivering agile and accelerated clinical development solutions for global biotechs, has further strengthened its presence in Asia with the opening of an office in Taipei, Taiwan.
- Simbec-Orion And Avance Clinical Consolidates Partnership With Memorandum Of Understanding 3/4/2025
-
Avance Clinical Leads As The CRO Of Choice For Early Phase Clinical Trials In Australia – Announced At Biotech Showcase 2025
1/14/2025
Wake Forest, NC, USA | Adelaide, Australia
Avance Clinical, a leading full-service global Contract Research Organization (CRO) known for delivering high-quality, agile clinical research services, is proud to announce it is the CRO of choice for Early Phase clinical trials in Australia with more than 52% of market share. Avance Clinical Australia leads in the active Phase I trials, registered on clinical trial registry ANZCTR (as of 17 December 2024). More than 80% of Avance Clinical clients are US biotechs.
Book a meeting with the Avance Clinical team at Biotech Showcase.
-
Avance Clinical Wins Premier's Business And Export Awards 2024
11/26/2024
Avance Clinical is thrilled to announce that it has again been named as a winner in the prestigious South Australian Premier’s Business and Export Awards 2024. This honor underscores Avance Clinical’s continued commitment to driving innovation and delivering world-class clinical trial solutions to the global market, and comes on the heels of winning the 2023 International Health Exporter of the Year at last year’s awards ceremony.
-
Avance Clinical Recognized As Finalist In 62nd Australian Export Awards For International Health
11/26/2024
Avance Clinical, a leading Australian Contract Research Organization (CRO), has been named a finalist in the prestigious 62nd Australian Export Awards, under the International Health category. This recognition highlights the company’s exceptional contributions to the global biotechnology sector, supported by its reputation for delivering high-quality data, fast clinical trial timelines, and innovative clinical trial solutions.
-
Avance Clinical CEO And Asia Director Sign MOUs With Key Clinical Trial Sites In Korea Around 2024 KoNECT
10/30/2024
Avance Clinical, a leading full-service global Contract Research Organization (CRO) known for delivering high-quality, agile clinical research services, is proud to announce the signing of three significant Memorandums of Understanding (MOUs) with key Korean clinical sites during KoNECT 2024 conference.
-
Join Avance Clinical At Biotech Showcase 2025
10/17/2024
Avance Clinical, with over 30 years of experience as a leading full-service Contract Research Organization (CRO), is looking forward to once again meet with biotechs at Biotech Showcase 2025.
With over 30 years of experience as a full-service Contract Research Organization (CRO) and known for our leading EARLY PHASE specialist clinical research in Australia, we are committed to delivering high-quality, compliant clinical trials.
-
Join Avance Clinical At The CNS Summit 2024
10/17/2024
Avance Clinical is thrilled to announce our participation in the CNS Summit 2024, taking place from November 10 – 13, 2024, in Boston, MA. The CNS Summit is a premier event dedicated to advancing clinical development and technology innovation in the Central Nervous System (CNS) therapeutic area. The Summit brings together a curated group of top decision makers from pharma, biotech, CROs, investigator sites, patient advocacy groups, investors and other stakeholders.